Latest Blogs

May 16, 2017
Dr. Julia Close invites women attending the ASCO Annual Meeting to be a part of conversations about gender in medicine at the Women's Networking Center, either by joining for planned session or simply by stopping by to meet colleagues and have a cup of coffee.
May 12, 2017
Mr. Todd Pickard considers the effect of the team on professional burnout. Is your team a source of conflict and disappointment, or a source of confidence?
May 08, 2017
If you say things of consequence, there may be consequences; but the alternative is to be inconsequential. Particularly in these tumultuous times for health care and research, we need to speak up!
May 08, 2017
Every time I’ve received a gift from a patient, I feel humbled and slightly embarrassed, for, really, I’m just doing my job. But I treasure each one, tangible or intangible.
Subscribe to this column

Don S. Dizon, MD, FACP

Don S. Dizon, MD, FACP, is an Associate Professor at Harvard Medical School and is Clinical Co-Director of Gynecologic Oncology at the Massachusetts General Hospital (MGH) Cancer Center, where he also is Founder and Director of the Oncology Sexual Health Clinic. Dr. Dizon serves as Chair for ASCO's Social Media Working Group and is Immediate Past Chair of the Cancer Communications Committee. In addition to his regular column on ASCOconnection.org, which has been honored with APEX awards in 2013 and 2014, he is a blogger for MGH and a Section Editor of Gynecologic Oncology at UpToDate. Dr. Dizon is a member of the Journal of Clinical Oncology Editorial Board, and Editor in Chief of the ASCO Educational Book. Follow Dr. Dizon on Twitter @drdonsdizon.

Dec 27, 2011
Around this time each year I find myself thinking about patients usually—and especially those that have passed away. I wonder how their families are coping, how their children are, and whether each day has gotten easier. I think about how my patients died—and whether or not I did enough to ensure...
Dec 06, 2011
Every once in a while I get an opportunity to speak at a meeting in which oncologists are not the primary audience. Of course, it is always to speak on either gynecologic- or breast-cancer-specific issues, but I always welcome the opportunity to educate a non-oncology audience about what we can do...
Oct 29, 2011
I was recently asked to comment on a study that sought to address the risk of ovarian cancer in women who undergo in vitro...
Oct 22, 2011
I was recently interviewed about breast cancer in young women, spurred by the recent disclosure that Giuliana Rancic, of E! Entertainment News, was diagnosed with breast cancer. It struck me as...
Oct 06, 2011
I am currently sitting with colleagues from across the country as we plan the 2012 Program, an honor and yet a daunting task! Searching pubmed, vetting potential speakers, and keeping abreast on office and business matters, I rely heavily on my laptop and web access, and dating back to 1986, I have...
Sep 24, 2011
I have followed with interest the exciting progress being made across oncology--progress in melanoma with the anti-CTLA agent iplimumab and the BRAF inhibitor,...

Pages